Journal of Lipid Research, Vol. 8, 202-209, May 1967
Copyright © 1967 by Lipid Research, Inc.

Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease

Peter B. Schneider and Eugene P. Kennedy

Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts 02115

This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. The enzyme, which is located in the subcellular particulate fraction that sediments between 700 and 8500 g, is readily made soluble and has been partially purified. Its pH optimum is between 4.5 and 5.0. It is unaffected by divalent cations, chelating agents, and sulfhydryl reagents, but is inhibited by phosphate. The enzyme attacks sphingomyelin and dihydrosphingomyelin, but is inactive toward sphingosine phosphoryl choline, O-acetylsphingomyelin, and lecithin. In some of its properties, the enzyme from human spleen is different from the previously studied sphingomyelinase from rat tissues.

The enzyme is absent or markedly reduced in spleens from patients with classical and visceral varieties of Niemann-Pick disease, but is present in normal amounts in the late infantile type of the disease. In the present study another enzyme, this one magnesium-dependent, capable of catalyzing the cleavage of sphingomyelin has been detected in the spleens of patients with the classical form of Niemann-Pick disease. Some implications of these findings for theories of the metabolic defect in Niemann-Pick disease are discussed.

Supplementary key words spleen • sphingomyelinase • man • sphingomyelin accumulation • Niemann-Pick disease • lipid storage disease

Submitted on October 31, 1966
Accepted on January 18, 1967

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. J. E. Bjorkqvist, T. K. M. Nyholm, J. P. Slotte, and B. Ramstedt Domain Formation and Stability in Complex Lipid Bilayers as Reported by Cholestatrienol Biophys. J., June 1, 2005; 88(6): 4054 - 4063. [Abstract] [Full Text] [PDF]

				L. Scheffer, I. Solomonov, M. J. Weygand, K. Kjaer, L. Leiserowitz, and L. Addadi Structure of Cholesterol/Ceramide Monolayer Mixtures: Implications to the Molecular Organization of Lipid Rafts Biophys. J., May 1, 2005; 88(5): 3381 - 3391. [Abstract] [Full Text] [PDF]

				T. K. M. Nyholm, M. Nylund, and J. P. Slotte A Calorimetric Study of Binary Mixtures of Dihydrosphingomyelin and Sterols, Sphingomyelin, or Phosphatidylcholine Biophys. J., May 1, 2003; 84(5): 3138 - 3146. [Abstract] [Full Text] [PDF]

				T. Nyholm, M. Nylund, A. Soderholm, and J. P. Slotte Properties of Palmitoyl Phosphatidylcholine, Sphingomyelin, and Dihydrosphingomyelin Bilayer Membranes as Reported by Different Fluorescent Reporter Molecules Biophys. J., February 1, 2003; 84(2): 987 - 997. [Abstract] [Full Text] [PDF]

				S. R. P. MIRANDA, X. HE, C. M. SIMONARO, S. GATT, A. DAGAN, R. J. DESNICK, and E. H. SCHUCHMAN Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology FASEB J, October 1, 2000; 14(13): 1988 - 1995. [Abstract] [Full Text]

				T. Langmann, C. Buechler, S. Ries, A. Schaeffler, C. Aslanidis, M. Schuierer, M. Weiler, K. Sandhoff, P. J. de Jong, and G. Schmitz Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation J. Lipid Res., May 1, 1999; 40(5): 870 - 880. [Abstract] [Full Text]

				B. Liu, D. F. Hassler, G. K. Smith, K. Weaver, and Y. A. Hannun Purification and Characterization of a Membrane Bound Neutral pH Optimum Magnesium-dependent and Phosphatidylserine-stimulated Sphingomyelinase from Rat Brain J. Biol. Chem., December 18, 1998; 273(51): 34472 - 34479. [Abstract] [Full Text] [PDF]

				S. L. Schissel, G. A. Keesler, E. H. Schuchman, K. J. Williams, and I. Tabas The Cellular Trafficking and Zinc Dependence of Secretory and Lysosomal Sphingomyelinase, Two Products of the Acid Sphingomyelinase Gene J. Biol. Chem., July 17, 1998; 273(29): 18250 - 18259. [Abstract] [Full Text] [PDF]

				W. Zundel and A. Giaccia Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress Genes & Dev., July 1, 1998; 12(13): 1941 - 1946. [Abstract] [Full Text]

				S. Reif, Z. Spirer, G. Messer, M. Baratz, B. Bembi, and Y. Bujanover Severe Failure to Thrive and Liver Dysfunction as the Main Manifestations of a New Variant of Niemann-Pick Disease Clinical Pediatrics, October 1, 1994; 33(10): 628 - 630. [PDF]

				J. W. Reagan Jr., M. L. Hubbert, and G. S. Shelness Posttranslational Regulation of Acid Sphingomyelinase in Niemann-Pick Type C1 Fibroblasts and Free Cholesterol-enriched Chinese Hamster Ovary Cells J. Biol. Chem., November 22, 2000; 275(48): 38104 - 38110. [Abstract] [Full Text] [PDF]